Page last updated: 2024-12-06

rolafagrel

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

rolafagrel: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID56009
CHEMBL ID2107064
SCHEMBL ID729065
MeSH IDM0181770

Synonyms (21)

Synonym
89781-55-5
rolafagrel [inn]
brn 4319596
rolafagrelum [inn-latin]
fce 22178
5,6-dihydro-7-imidazol-1-yl-2-naphthoic acid
2-naphthalenecarboxylic acid, 5,6-dihydro-7-(1h-imidazol-1-yl)-
rolafagrel
7-imidazol-1-yl-5,6-dihydronaphthalene-2-carboxylic acid
rolafagrelum
oah71568y4 ,
unii-oah71568y4
2-naphthalenecarboxylicacid, 5,6-dihydro-7-(1h-imidazol-1-yl)-
CHEMBL2107064
SCHEMBL729065
AKOS022660973
rolafagrel [who-dd]
DQEDSIVMYUUZCK-UHFFFAOYSA-N
1,2-dihydro-3-(1-imidazolyl)-6-carboxy-naphthalene
DTXSID30237887
Q27285540

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" No drug-related adverse experiences were observed over the studied dose range after single doses at FCE 22,178."( A phase I dose-ranging safety and pharmacokinetics study of a novel oral thromboxane synthase inhibitor, FCE 22, 178.
Colborn, DC; Hatfield, NZ; Lewis, RC; Li, RC; Narang, PK; Rossi, DT, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (27.27%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (72.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]